From detection to decision: how laboratory testing and reporting strategies can shape management of carbapenemase-producing Enterobacterales infections
Abstract
ABSTRACT Antimicrobial resistance mediated by carbapenemases significantly complicates treatment options. A case report by Morelan et al. (ASM Case Reports 1:e00094-25, 2025, https://doi.org/10.1128/asmcr.00094-25) illustrates how delayed recognition of Klebsiella pneumoniae carbapenemase (KPC) production in an Escherichia coli urinary tract infection resulted in suboptimal cefepime therapy, despite in vitro susceptibility. This case underscores the urgent need for clinical laboratories to implement on-site carbapenemase testing, as recommended by the Infectious Diseases Society of America and the Clinical and Laboratory Standards Institute (CLSI). Timely detection of KPC, coupled with reporting strategies for cefepime susceptibility results (suppression or editing results as resistant) in carbapenemase producers, may have facilitated earlier administration of a more appropriate antimicrobial and prevented recurrent infections and readmissions. In this commentary, we highlight recent updates to CLSI guidance for carbapenemase testing and antimicrobial susceptibility reporting strategies. Using this case report as an example, we outline the potential impact of these strategies on patient management and outcomes, further emphasizing the role of the clinical microbiology laboratory in antimicrobial stewardship.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.